METHOD FOR DETERMINING PRESENCE OR ABSENCE OF RISK OF DEVELOPING CANCER
An object of the present invention is to provide a method for predicting a risk of developing cancer. DNA samples were prepared from blood and cancer tissues of 2480 cancer patients and analyzed for the nucleotide sequences of exon regions using NGS. As a result, among the cancer patients, 7 patient...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HATAKEYAMA, Keiichi SHIMODA, Yuji MARUYAMA, Kouji OHSHIMA, Keiichi ISHIKAWA, Yoshinobu YAMAGUCHI, Ken SERIZAWA, Masakuni MOCHIZUKI, Tohru OHNAMI, Shumpei KUSUHARA, Masatoshi AKIYAMA, Yasuto NAGASHIMA, Takeshi URAKAMI, Kenichi INOUE, Kengo |
| description | An object of the present invention is to provide a method for predicting a risk of developing cancer. DNA samples were prepared from blood and cancer tissues of 2480 cancer patients and analyzed for the nucleotide sequences of exon regions using NGS. As a result, among the cancer patients, 7 patients were confirmed to have D49H mutation or A159D mutation which is a germ cell mutation. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2020255901A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2020255901A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2020255901A13</originalsourceid><addsrcrecordid>eNrjZHD3dQ3x8HdRcPMPUnBxDXEN8vX08_RzVwgIcg129XN2VQCKOzpBmW4KQZ7B3iDaxTXM1cc_AKTS2REoF8TDwJqWmFOcyguluRmU3VxDnD10Uwvy41OLCxKTU_NSS-JDg40MgNDU1NLA0NHQmDhVAF_ULRc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR DETERMINING PRESENCE OR ABSENCE OF RISK OF DEVELOPING CANCER</title><source>esp@cenet</source><creator>HATAKEYAMA, Keiichi ; SHIMODA, Yuji ; MARUYAMA, Kouji ; OHSHIMA, Keiichi ; ISHIKAWA, Yoshinobu ; YAMAGUCHI, Ken ; SERIZAWA, Masakuni ; MOCHIZUKI, Tohru ; OHNAMI, Shumpei ; KUSUHARA, Masatoshi ; AKIYAMA, Yasuto ; NAGASHIMA, Takeshi ; URAKAMI, Kenichi ; INOUE, Kengo</creator><creatorcontrib>HATAKEYAMA, Keiichi ; SHIMODA, Yuji ; MARUYAMA, Kouji ; OHSHIMA, Keiichi ; ISHIKAWA, Yoshinobu ; YAMAGUCHI, Ken ; SERIZAWA, Masakuni ; MOCHIZUKI, Tohru ; OHNAMI, Shumpei ; KUSUHARA, Masatoshi ; AKIYAMA, Yasuto ; NAGASHIMA, Takeshi ; URAKAMI, Kenichi ; INOUE, Kengo</creatorcontrib><description>An object of the present invention is to provide a method for predicting a risk of developing cancer. DNA samples were prepared from blood and cancer tissues of 2480 cancer patients and analyzed for the nucleotide sequences of exon regions using NGS. As a result, among the cancer patients, 7 patients were confirmed to have D49H mutation or A159D mutation which is a germ cell mutation.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200813&DB=EPODOC&CC=US&NR=2020255901A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200813&DB=EPODOC&CC=US&NR=2020255901A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HATAKEYAMA, Keiichi</creatorcontrib><creatorcontrib>SHIMODA, Yuji</creatorcontrib><creatorcontrib>MARUYAMA, Kouji</creatorcontrib><creatorcontrib>OHSHIMA, Keiichi</creatorcontrib><creatorcontrib>ISHIKAWA, Yoshinobu</creatorcontrib><creatorcontrib>YAMAGUCHI, Ken</creatorcontrib><creatorcontrib>SERIZAWA, Masakuni</creatorcontrib><creatorcontrib>MOCHIZUKI, Tohru</creatorcontrib><creatorcontrib>OHNAMI, Shumpei</creatorcontrib><creatorcontrib>KUSUHARA, Masatoshi</creatorcontrib><creatorcontrib>AKIYAMA, Yasuto</creatorcontrib><creatorcontrib>NAGASHIMA, Takeshi</creatorcontrib><creatorcontrib>URAKAMI, Kenichi</creatorcontrib><creatorcontrib>INOUE, Kengo</creatorcontrib><title>METHOD FOR DETERMINING PRESENCE OR ABSENCE OF RISK OF DEVELOPING CANCER</title><description>An object of the present invention is to provide a method for predicting a risk of developing cancer. DNA samples were prepared from blood and cancer tissues of 2480 cancer patients and analyzed for the nucleotide sequences of exon regions using NGS. As a result, among the cancer patients, 7 patients were confirmed to have D49H mutation or A159D mutation which is a germ cell mutation.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD3dQ3x8HdRcPMPUnBxDXEN8vX08_RzVwgIcg129XN2VQCKOzpBmW4KQZ7B3iDaxTXM1cc_AKTS2REoF8TDwJqWmFOcyguluRmU3VxDnD10Uwvy41OLCxKTU_NSS-JDg40MgNDU1NLA0NHQmDhVAF_ULRc</recordid><startdate>20200813</startdate><enddate>20200813</enddate><creator>HATAKEYAMA, Keiichi</creator><creator>SHIMODA, Yuji</creator><creator>MARUYAMA, Kouji</creator><creator>OHSHIMA, Keiichi</creator><creator>ISHIKAWA, Yoshinobu</creator><creator>YAMAGUCHI, Ken</creator><creator>SERIZAWA, Masakuni</creator><creator>MOCHIZUKI, Tohru</creator><creator>OHNAMI, Shumpei</creator><creator>KUSUHARA, Masatoshi</creator><creator>AKIYAMA, Yasuto</creator><creator>NAGASHIMA, Takeshi</creator><creator>URAKAMI, Kenichi</creator><creator>INOUE, Kengo</creator><scope>EVB</scope></search><sort><creationdate>20200813</creationdate><title>METHOD FOR DETERMINING PRESENCE OR ABSENCE OF RISK OF DEVELOPING CANCER</title><author>HATAKEYAMA, Keiichi ; SHIMODA, Yuji ; MARUYAMA, Kouji ; OHSHIMA, Keiichi ; ISHIKAWA, Yoshinobu ; YAMAGUCHI, Ken ; SERIZAWA, Masakuni ; MOCHIZUKI, Tohru ; OHNAMI, Shumpei ; KUSUHARA, Masatoshi ; AKIYAMA, Yasuto ; NAGASHIMA, Takeshi ; URAKAMI, Kenichi ; INOUE, Kengo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2020255901A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>HATAKEYAMA, Keiichi</creatorcontrib><creatorcontrib>SHIMODA, Yuji</creatorcontrib><creatorcontrib>MARUYAMA, Kouji</creatorcontrib><creatorcontrib>OHSHIMA, Keiichi</creatorcontrib><creatorcontrib>ISHIKAWA, Yoshinobu</creatorcontrib><creatorcontrib>YAMAGUCHI, Ken</creatorcontrib><creatorcontrib>SERIZAWA, Masakuni</creatorcontrib><creatorcontrib>MOCHIZUKI, Tohru</creatorcontrib><creatorcontrib>OHNAMI, Shumpei</creatorcontrib><creatorcontrib>KUSUHARA, Masatoshi</creatorcontrib><creatorcontrib>AKIYAMA, Yasuto</creatorcontrib><creatorcontrib>NAGASHIMA, Takeshi</creatorcontrib><creatorcontrib>URAKAMI, Kenichi</creatorcontrib><creatorcontrib>INOUE, Kengo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HATAKEYAMA, Keiichi</au><au>SHIMODA, Yuji</au><au>MARUYAMA, Kouji</au><au>OHSHIMA, Keiichi</au><au>ISHIKAWA, Yoshinobu</au><au>YAMAGUCHI, Ken</au><au>SERIZAWA, Masakuni</au><au>MOCHIZUKI, Tohru</au><au>OHNAMI, Shumpei</au><au>KUSUHARA, Masatoshi</au><au>AKIYAMA, Yasuto</au><au>NAGASHIMA, Takeshi</au><au>URAKAMI, Kenichi</au><au>INOUE, Kengo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR DETERMINING PRESENCE OR ABSENCE OF RISK OF DEVELOPING CANCER</title><date>2020-08-13</date><risdate>2020</risdate><abstract>An object of the present invention is to provide a method for predicting a risk of developing cancer. DNA samples were prepared from blood and cancer tissues of 2480 cancer patients and analyzed for the nucleotide sequences of exon regions using NGS. As a result, among the cancer patients, 7 patients were confirmed to have D49H mutation or A159D mutation which is a germ cell mutation.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2020255901A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE |
| title | METHOD FOR DETERMINING PRESENCE OR ABSENCE OF RISK OF DEVELOPING CANCER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A11%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HATAKEYAMA,%20Keiichi&rft.date=2020-08-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2020255901A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |